This Startup Backed By OpenAI and the Jobs Family Is the Latest A.I. Drug Discovery Unicorn Chai Discovery more than doubled its valuation to $1.3 billion after raising $130 million to advance A.I.-powered drug development. By Alexandra Tremayne-Pengelly
The Crisis King Who Builds Careers: Inside Matthew Hiltzik’s Paradoxical Empire The most relentless fixer of the last twenty years has launched an unusually potent network of protégés into the highest echelons of corporate America. By Merin Curotto
OpenAI Is On Track to Become the World’s Most Valuable Private Company A new secondary share sale could make OpenAI the highest-valued private firm in the world. By Sissi Cao
OpenAI Secures $10B in One Week—But It’s Also Burning Cash at Record Speed By Alexandra Tremayne-Pengelly
NYC Online Pharmacy Startup Capsule to Bring Prescription Drug Delivery Nationwide By Gabriela Barkho
Facebook Acquires Instagram For $1 B. Just Days After a $50 M. Investment From Sequoia, Thrive, and Greylock [UPDATED] By Nitasha Tiku
The Agony, the Ecstasy, and the Karaoke: Twitter Reactions to the GroupMe/Skype Acquisition By Nitasha Tiku
Craig Shapiro of Collaborative Fund and GOOD Talks BankSimple, Drudge Report, Socially-Conscious Investing, and the Start-Up He’d Most Like to See By Adrianne Jeffries